Assessment of HIV Testing of Urban Injection Drug Users
Implications for Expansion of HIV Testing and Prevention Efforts
Bibliographic Data
Objectives. We sought to determine the extent of HIV testing among urban injection drug users (IDUs) to assess whether an expansion of targeted testing programs would be consistent with national goals to identify previously undetected infections. Methods. IDUs in 5 US cities (Oakland, Calif; Chicago, Ill; Hartford and New Haven, Conn; and Springfield, Mass) were recruited either by chain referral or time–location sampling. The IDUs were questioned about HIV testing, and factors associated with HIV testing were analyzed. Results. Ninety-three percent of 1543 IDUs had been tested. Among those tested but who did not report having been told that they were HIV seropositive, 90% had been tested within the past 3 years. Women and syringe-exchange customers were more likely to have been tested ever and in the recent past. We estimated the number of undetected infections among urban IDUs in the United States to be less than 40000. Conclusions. Testing for HIV has reached the vast majority of IDUs through the current options. Expending scarce prevention money to expand testing of IDUs is unlikely to be productive. Instead, resources should be used for proven HIV-prevention strategies including syringe exchange, drug treatment, and secondary prevention for those who are HIV positive
Drug injection · Environmental health · Family medicine · Human immunodeficiency virus (HIV) · Injection drug use · Psychiatry · Referral · Syringe · HIV, Drug Use, Sexual Risk · HIV/AIDS Research and Interventions · Medicine · Sex work and related issues
Helping behaviour among people who use drugs
Associations Between Injection Risk and Community Disadvantage Among Suburban Injection Drug Users in Southwestern Connecticut, USA
High HIV Prevalence, Suboptimal HIV Testing, and Low Knowledge of HIV-Positive Serostatus Among Injection Drug Users in St. Petersburg, Russia
Identifying Which Place Characteristics are Associated with the Odds of Recent HIV Testing in a Large Sample of People Who Inject Drugs in 19 US Metropolitan Areas
Uptake of HIV Testing in Substance Use Disorder Treatment Programs That Offer On-Site Testing
Self-Reported HIV and HCV Screening Rates and Serostatus Among Substance Abuse Treatment Patients
Social and individual risk determinants of HIV testing practices among noninjection drug users at high risk for HIV/Aids
Adoption and utilization of sexually transmitted infections testing in outpatient substance abuse treatment facilities serving high risk populations in the U.S
Community coverage and HIV prevention
Hiv Counseling and Testing Among Injection Drug Users Needs to Continue
Seroprevalence of HIV, Hepatitis B Virus, and HCV Among Injection Drug Users in Connecticut
Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic
Needle exchange is not enough
Meta-Analysis of High-Risk Sexual Behavior in Persons Aware and Unaware They are Infected With HIV in the United States
Effects of Increasing Syringe Availability on Syringe-Exchange Use and HIV Risk
Pilot Study to Enhance HIV Care Using Needle Exchange-Based Health Services for Out-of-Treatment Injecting Drug Users
Lessons from the Field
Drug Sharing Among Heroin Networks
Correlates of HIV Antibody Testing Among a Sample of Injection Drug Users
HIV transmission and HIV prevention associated with injecting drug use in the Russian Federation
Prevalence and Incidence of HIV, Hepatitis B Virus, and Hepatitis C Virus Infections Among Males in Rhode Island Prisons
HIV Incidence Among Injection Drug Users in New York City, 1990 to 2002
HIV seroprevalence among street-recruited injection drug and crack cocaine users in 16 US municipalities
Neighborhood Differences in Patterns of Syringe Access, Use, and Discard Among Injection Drug Users
| Citations per year | 0.58 |
|---|---|
| Citation span | 2007 - 2019 (13) |
| Highly cited | No |